Slow-onset, long-duration 3-(3′,4′-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse

Journal of Medicinal Chemistry

Volumn 43, Issue 26, 2000, Pages 4981-4992

  Froimowitz, M ^a   Wu, K M ^a   Moussa, A ^a   Haidar, R M ^a   Jurayj, J ^a   George, C ^b   Gardner, E L ^c  

^a Laboratory for the Structure of Matter   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3',4' DICHLOROPHENYL) 1 INDANAMINE MONOAMINE; COCAINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; NITROGEN DERIVATIVE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; CIS ISOMER; COCAINE DEPENDENCE; DRUG MECHANISM; DRUG STRUCTURE; ENANTIOMER; LOCOMOTION; MAINTENANCE THERAPY; X RAY CRYSTALLOGRAPHY;

ANIMALS; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; COCAINE-RELATED DISORDERS; CRYSTALLOGRAPHY, X-RAY; DISCRIMINATION LEARNING; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; INDANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

EID: 0034727852     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000201d     Document Type: Article

References (59)

1. Cocaine receptors on dopamine transporters are related to self-administration of cocaine
2. The dopamine hypothesis of the reinforcing properties of cocaine
3. Relationship between subjective effects of cocaine and dopamine transporter occupancy
4. Effects of cocaine and related drugs in non-human primates. III. Self-administration by squirrel monkeys
5. New concepts in cocaine addiction: The dopamine depletion hypothesis
6. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration
7. Post-cocaine-depression and sensitization of brain stimulation reward. Analysis of reinforcement and performance effects
8. Postcocaine anhedonia. An animal model of cocaine withdrawal
9. Genetic approaches to the analysis of addiction processes
10. Genetic influences in drug abuse
11. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis
12. Prediction of reinforcing responses to psychostimulants in humans by dopamine D2 receptor levels
13. Medications development at the National Institute on Drug Abuse: Focus on cocaine
14. Management of cocaine abuse and dependence
15. Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects
16. 3H]DA-uptake inhibition to transporter-binding inhibition ratios for the in vitro evaluation of putative cocaine antagonists
17. Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: Discovery of a weak cocaine 'Antagonist'
18. Some relationships between addiction and drug delivery to the brain
19. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain
20. Nicotine metabolism defect reduces smoking
21. Comparative study of the electroencephalographic and behavioral effects of l-α-Acetylmethadol (LAAM), Two of its metabolites and morphine methadone in the rat
22. 2]acetylnormethadol (Nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkey
23. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl)piperaziny l decanoate, a long-acting ester derivative of GBR 12909
24. Conformational analysis of cocaine, the potent analogue 2β-Carbomethoxy-3β-(4-fluorophenyl)tropane (CFT), and other dopamine reuptake blockers
25. Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT
26. Further evidence for a dopamine reuptake pharmacophore. The effect of N-methylation on threo-methylphenidate and analogues
27. Conformational analysis and a crystal structure of bupropion, an antidepressant with dopamine reuptake blocking activity
28. Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion
29. Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogues and their incorporation into a pharmacophore model
30. Stereoselective behavioral effects of Lu 19-005 in monkeys: Relation to binding at cocaine recognition sites
31. 3-Phenyl-l-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake
32. Modification of behavioral effects of cocaine by selective serotonin and dopamine reuptake inhibitors in squirrel monkeys
33. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey
34. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens
35. 3 receptor activation in medial prefrontal cortex of freely moving rats
36. Serotonin-facilitated dopamine release in vivo pharmacological characterization
37. Cocaine self-administration in dopamine-transporter knockout mice
38. Nontricyclic antidepressant agents derived from cis- and trans-1-Amino-4-aryltetralins
39. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships
40. Substituted 3-phenyltropane analogues of cocaine: Synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging
41. Synthesis pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogues
42. Halogenated mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter
43. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-(Aminomethyl)-3-phenylbicyclo[2.2.2]- and [2.2.1]-alkane dopamine uptake inhibitors
44. Efficient synthesis of a phosphinate bis-amino acid its Use in the construction of amphiphilic peptides
45. Effects of a slow-onset, long-lasting dopamine reuptake blocker on cocaine self-administration and on nucleus accumbens dopamine
46. Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkey
47. Differential binding and dopamine uptake activity of cocaine analogues modified at nitrogen
48. Structure-activity relationship studies of N-sulfonyl analogues of cocaine: Role of ionic interaction in cocaine binding
49. Modeling of the pH dependence of the binding of WIN 35, 428 to the dopamine transporter in rat striatal membranes: Is the bioactive form positively charged or neutral?
50. Nitrogen-based drugs are not essential for blockade of monoamine transporters
51. 2-Carbomethoxy-3-ary-8-oxabicyclo-[3.2.1]octanes: Potent non-nitrogen inhibitors of monoamine transporters
52. Bicyclo[3.2.1]octanes: Synthesis and inhibition of binding at the dopamine and serotonin transporters
53. Synthesis of 8-Oxa analogues of norcocaine endowed with interesting cocaine-like activity
54. Tuning the selectivity of monoamine transporter inhibitors by the stereochemistry of the nitrogen lone pair
55. On enantiomorph-polarity estimation